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Involvement of the CXCL12/CXCR4 Pathway
in the Recovery of Skin Following Burns
Shani Avniel1,9, Zaretski Arik2,9, Alex Maly3, Assa Sagie2, Hanna Ben Basst4, Merav Darash Yahana1,
Ido D. Weiss1, Boaz Pal1, Ori Wald1, Dean Ad-El5, Nobutaka Fujii6, Fernando Arenzana-Seisdedos7,
Steffen Jung8, Eithan Galun1, Eyal Gur2 and Amnon Peled1
Burn wound healing is a complex process consisting of an inflammatory phase, the formation of granulation
tissue, and remodeling. The role of the CXCL12/CXCR4 pathway in the recovery of skin following burns is
unknown. We found that CXCL12 is similarly expressed in human, swine, and rat skin by pericyte and
endothelial cells, fibrous sheet, fibroblasts, and axons. Following burns, the levels of CXCL12 were markedly
increased in human burn blister fluids. One day after injury, there was a gradual increase in the expression of
CXCL12 in the hair follicles and in blood vessel endothelium surrounding the burn. Three to 11 days following
burns, an increased number of fibroblasts expressing CXCL12 were observed in the recovering dermis of rat,
swine, and human skin. In contrast to CXCL12, CXCR4 expression was detected in proliferating epithelial cells as
well as in eosinophils and mononuclear cells infiltrating the skin. In vitro, CXCL12 was expressed by primary
human skin fibroblasts, but not by keratinocytes, and was stimulated by wounding a confluent cell layer of
these fibroblasts. Blocking the CXCR4/CXCL12 axis resulted in the significant reduction in eosinophil
accumulation in the dermis and improved epithelialization. Thus, blocking CXCR4/CXCL12 interaction may
significantly improve skin recovery after burns.
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INTRODUCTION
Skin integrity is of importance for the protection and
separation of body tissues from the surrounding environment.
The loss of skin due to burns or trauma exposes the body to
severe stress, impairing or even eliminating the many vital
functions this organ performs (Clark, 1988; Cotran et al.,
1999). Full-thickness skin tissue is comprised of keratinocytes
lined on a basement membrane, produced by fibroblasts and
keratinocytes. Deeper layers of the skin include, in addition
to fibroblasts, fat cells and multiple subsets of immune cells
such as dendritic cells, lymphocytes, and polymorphonuclear
cells. The complex organization of normal skin is designed to
support the numerous functions of this organ as both an
immunologic and a physical barrier. Nevertheless, not much
is known about the factors responsible for the complex
architecture of this organ under physiologic and pathologic
conditions.
Stromal-derived factor-1 (CXCL12) controls many aspects
of stem cell function. CXCL12 has been identified as a
powerful chemoattractant for immature hematopoietic stem
cells (Aiuti et al., 1997). Mice that lack either CXCL12 or its
receptor CXCR4 exhibit many defects, including impaired
hematopoiesis in the fetal bone marrow (Nagasawa et al.,
1996; Ma et al., 1998; Zou et al., 1998; McGrath et al.,
1999). Recently, it was shown that mobilization, homing, and
engraftment of hematopoietic stem cells as well as the
trafficking of neuronal and primordial germ cells are
dependent on the expression of CXCL12 and CXCR4 (Peled
et al., 1999; Doitsidou et al., 2002). Furthermore, it was also
shown that the expression of CXCL12 is upregulated
following irradiation and hypoxia and that CXCL12 can
induce the recruitment of endothelial progenitor cells in a
regeneration model for myocardial infarction (Ponomaryov
et al., 2000; Askari et al., 2003; Ceradini et al., 2004). The
regulation of CXCL12 and its physiological role in peripheral
tissue repair remain incompletely understood. A recent study
showed that CXCL12 gene expression is regulated by the
transcription factor hypoxia-inducible factor-1 in endothelial
cells, resulting in the selective in vivo expression of CXCL12
in ischemic tissue in direct proportion to reduced oxygen
tension (Hitchon et al., 2002; Schioppa et al., 2003).
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Hypoxia-inducible factor-1-induced CXCL12 expression was
suggested to increase the adhesion, migration, and homing of
circulating CXCR4-positive progenitor cells to ischemic
tissue.
Thus, CXCL12 plays an important role in the organization
of tissues during development and following damage.
CXCL12 is expressed by dendritic cells, fibroblasts, and
endothelial cells in human skin (Pablos et al., 1999). Here,
we show that following burns, the levels of CXCL12 is
markedly increased first in the burn blister and then in the
junction tissues surrounding the burn, hair follicles, endo-
thelium blood vessels and fibroblasts in the recovering
dermis. Treatment of partial thickness burns in a rat model
with antibodies to CXCR4 or the small peptide CXCR4
antagonist, 4F-benzoyl-TN14003 (Tamamura et al., 2003),
resulted in improved epithelialization and reduced eosino-
philia. These observations suggest a role for eosinophils and
the CXCL12/CXCR4 pathway in wound healing and in the
recovery of burn skin.
RESULTS
CXCL12 is similarly expressed in human, swine, and rat normal
skin
The expression of CXCL12 in normal skin was examined by
immunohistochemical staining using monoclonal antibody
(mAB) (MAB 350) (R&D Systems Inc., Minneapolis, Minnesota)
against the chemokine CXCL12. We first examined the
antibody crossreactivity of CXCL12 staining on liver sections
of mouse, human, and rat, since previous studies have shown
that CXCL12 is specifically expressed in the bile ducts and
blood vessels of human liver (Wald et al., 2004). In mouse,
human, and rat, liver bile ducts were specifically stained with
MAB 350 for CXCL12 (data not shown). Control stain without
the primary Ab showed no staining. Using the same mAB
staining for CXCL12 in human, swine, and rat, normal skin
showed similar expression patterns. CXCL12 in human
normal skin (Figure 1) was detected in the basal layer of the
epidermis (Figure 1a), on scattered cells in the papillary
dermis (Figure 1b), in pericytes, and in the endothelial layer
of blood vessels (Figure 1c). The fibrous sheet of hair follicles
(Figure 1d), sweat glands (not uniformly) (Figure 1e), axons,
and small blood vessels in the nerve tissue (Figure 1f)
also expressed CXCL12. No staining was detected with a
control antibody used to stain identical skin sections (Figure
1g–h). CXCL12 was detected in rat normal skin on the basal
layer of the epidermis (Figure 2a), on scattered cells in the
papillary dermis (Figure 2b), and on pericytes and the
endothelial layer of blood vessels (Figure 2c). The chemokine
CXCL12 was also expressed by axons and small blood vessels
in the nerve tissue (Figure 2d) and by fibrous sheet of hair
follicles (Figure 2e). No staining was detected with control
antibody used to stain the same skin sections (Figure 2f). The
Hair follicle Sweat glands
×400 ×400 ×400
×400×400×400
Nerve tissue
Epidermis Papillary dermis Blood vessel
×400
Epidermis Epidermis
×400
a b c
d e
g h
f
Figure 1. Expression of CXCL12 in normal human skin. Immunohistochemistry staining results using a monoclonal antibody against the chemokine CXCL12 on
human normal skin section. (a) Stained cells in the basal layer of the epidermis. (b) Scattered cells stained in the papillary dermis. (c) Endothelial cells and
pericytes stained in blood vessel. (d) Fibrous sheet stained in the hair follicle. (e) Sweat glands not uniformly stained. (f) Axons and blood vessels stained in nerve
tissue. (g) Sections of epidermis and papillary dermis were stained without the primary antibody ensuring that no background staining was received from the
second antibody. (h) Sections of epidermis and papillary dermis were stained with the primary antibody after incubation with CXCR4 ligands CXCL12a and
CXCL12b ensuring that the staining is specific for CXCL12. (Original magnification400).
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chemokine CXCL12 was similarly expressed by swine normal
skin cells in the basal layer of the epidermis (Figure 2g), by
scattered cells in the papillary dermis (Figure 2h), in
pericytes, and by the endothelial layer of blood vessels
(Figure 2i). The chemokine CXCL12 was also expressed by
fibrous sheets of hair follicles (Figure 2j) and by sweat glands
(Figure 2k). No staining was detected with control antibody
used to stain the same skin sections (Figure 2l). This unique
and conserved expression pattern of CXCL12 may suggest a
role for CXCR4/CXCL12 axis in the organization of skin
tissue.
Following burns, the level of CXCL12 was markedly
increased in human burn blister fluids, hair follicles, blood
vessels endothelium, and fibroblasts in the recovering dermis
of rat, swine, and human skin.
In order to study the effect of burn injury on CXCL12
expression in the skin, we first collected burn wound fluids,
and CXCL12 levels were measured by ELISA assay and
compared to the levels of IL-8 (Figure 3a and b). The results
indicate a unique pattern of the chemokine CXCL12
expression compared to the IL-8. IL-8 appeared first in the
burn fluid a few hours after injury, reached a plateau level
after 1 day, and remained at the same level for the next 4
days. CXCL12 appeared a few hours after injury, reached a
plateau level after 1 day, and remained at the
same level for an additional 2 days, and then the level of
CXCL12 decreased exponentially. The consistent overexpres-
sion of IL-8 in burn wound fluids and skin tissue has also been
reported by others (Iocono et al., 2000). These authors
suggested that IL-8 has a role in stimulating neutrophils
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Figure 2. Expression of CXCL12 in rat and swine normal skin. (a–f) Immunohistochemical staining results using monoclonal antibody against the chemokine
CXCL12 on rat normal skin sections. (a) Cells stained in the basal layer of the epidermis. (b) Scattered cells stained in the papillary dermis. (c) Endothelial cells
and pericytes stained in blood vessel. (d) Axons and blood vessels stained in nerve tissue. (e) Fibrous sheet stained in the hair follicle. (f) Epidermis and papillary
dermis control staining, without the primary antibody (original magnification of  400). (g–l) Immunohistochemical staining results using monoclonal antibody
against the chemokine CXCL12 on swine normal skin sections. (g) Cells stained in the basal layer of the epidermis and the papillary dermis. (h) Scattered cells
stained in the papillary dermis. (i) Endothelial cells and pericytes stained in blood vessel. (j) Fibrous sheet stained in the hair follicle. (k) Sweat glands staining.
(l) control staining, without the primary antibody. (Original magnifications200 or400).
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migration and accelerating the angiogenic process within the
burn wound.
The expression of the chemokine CXCL12 following burn
infliction was further examined by immunohistochemical
staining of rat skin sections. The results shown in Figure 5
indicate accumulation of CXCL12 in the rat burned skin in
correlation with time. Six days and 1 day after injury, CXCL12
was not detected in the burned tissue. Three days postburn,
CXCL12 was detected in endothelium blood vessels, in the
hair follicles, and also in scattered cells accumulated in the
dermis. Five and 7 days postburn, a higher expression of the
chemokine was detected in blood vessels and in fibroblast-
like cells accumulated in the dermis. As was shown before for
human normal skin, CXCR4 was detected in normal and
proliferating rat epithelial cells and endothelial cells after
burn injury (Figure 4). In the dermis of injured skin, CXCR4
expression was also detected in mononuclear cells as well as
infiltrating eosinophils.
The pattern of CXCL12 expression in swine skin postburn
is similar. Four days postburn, CXCL12 was present in
endothelium blood vessels and in scattered cells that
accumulated in the papillary dermis. Ten days after injury,
a strong expression of the chemokine was detected in blood
vessels and in the accumulating fibroblast-like cell popula-
tion in the papillary dermis of normal skin stained for CXCL12
is shown in Figure 5c.
In order to determine the cell types that expressed high
levels of CXCL12, we stained parallel sections from burned
skin for vimentin and CXCL12. The majority of fibroblast-like
cells were stained for both CXCL12 and vimentin indicating
that fibroblasts were expressing CXCL12 in the skin following
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Figure 3. (a) IL-8 and (b) CXCL12 mean levels (pg/ml) in human burn wound
fluid collected from blisters of patients with second degree burn. Fluids were
collected 0–5 days after burn as a medical treatment protocol. Samples were
measured for the chemokines by ELISA assays. Each point represents one
patient.
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Figure 4. The involvement of CXCL12 in rat and swine burn wound healing. Expression of CXCL12 in rat burn wound healing. (a) Immunohistochemical
staining of CXCL12 of rat epidermis burned skin sections, at 6 hours, 1 day, 3 days, 5 days, and 7 days after the burn. Staining for CXCR4 is shown at 7 days after
the burn (original magnifications 100, 200). (b) Immunohistochemical staining of CXCL12 of rat dermis burned skin sections, at 6, 72, and 120 hours after
the burn (original magnifications 100,  200). (c) Expression of CXCL12 in swine skin after second-degree burn. Immunohistochemical staining of CXCL12 at
4 days, 10 days after the burn, and at time 0 in normal skin. (Original magnifications100,  400).
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burn injury (Figure 5a and b). However, part of the cells that
expressed CXCL12 did not express vimentin. CXCL12 was
shown to be expressed by human dendritic cells localized to
the epidermis and the dermis (Pablos et al., 1999). An
excellent means to track monocyte subsets in the skin was
through the use of mice bearing a green fluorescent protein
(GFP) reporter knocked-in to the CX3CR1 chemokine
receptor locus (Qu et al., 2004). Indeed, we found that
following injury, monocyte with a dendritic-like shape
accumulated in the dermis and epidermis (Figure 5c and d).
Part of the monocyte/dendritic cells that expressed the GFP
also expressed CXCL12 (Figure 5e–h).
To further study the expression of CXCL12 and CXCR4 in
the skin, we used primary skin fibroblast and keratinocyte
cultures. In agreement with our in vivo results, we found that
while the fibroblasts expressed the chemokine CXCL12 in the
mRNA level, the keratinocytes did not. In contrast to
CXCL12, keratinocytes, but not the fibroblasts, expressed
the receptor CXCR4. In order to verify our finding, we used
ELISA assay to check the production of CXCL12 by
keratinocytes and fibroblasts. The results demonstrated that
while keratinocytes did not express the chemokine CXCL12
at the protein level, fibroblasts did express and secrete
CXCL12 (Figure 6a), especially during the recovery of skin
fibroblasts migrating into the wound area and accumulating
in the dermis. In order to study the effect of wounding on
CXCL12 expression by skin fibroblasts, a ‘‘scratching’’ assay
was performed on confluent layers of human skin fibroblasts
in vitro. Immunohistochemical staining of confluent human
skin fibroblasts showed moderate CXCL12 expression. Two
days following scratching, an increase in CXCL12 expression
by cells adjacent to the affected area was detected (Figure 6d).
Fibroblast monolayers were negatively stained with control
antibody against cytokeratin.
Inhibition of the CXCL12/CXCR4 pathway resulted in reduced
eosinophil accumulation and improved epithelialization
In order to evaluate the effect of the CXCR4 antagonist,
4F-benzoyl-TN14003, and neutralizing antibodies to the
receptor on the recovery of rat skin, we first tested their
ability to inhibit the migration of rat lymphocytes in response
to CXCL12. Migration assay was carried out on total rat
lymphocytes separated by Ficoll gradient, and their migrating
ability to medium containing CXCL12 was examined.
Lymphocytes were incubated with the CXCR4 antagonist,
4F-benzoyl-TN14003, and an antibody against CXCR4.
Treatment of cells with 4F-benzoyl-TN14003 exerted a
strong inhibitory effect, whereas treatment of cells with
neutralizing antibodies to CXCR4 exerted moderate effect on
the migration of cells in response to CXCL12 (Figure 7a).
Next, we examined the inhibitory effect of CXCR4
antagonists on burn wound healing (Figure 7b–d). Inhibitors
were injected subcutaneously to the burned area at 0, 1 day,
and 3 days, and animals were killed 5 days postburn.
Animals injected with the CXCR4 inhibitor, 4F-benzoyl-
TN14003, showed an increased epithelialization (Figure 7b).
A small but not significant decrease in the polymorpho-
nuclear cell population in the dermis was observed (Figure
7c). However, a strong and significant inhibition in eosino-
phil accumulation in the dermis was found in the 4F-benzoyl-
TN14003 and antibodies to the CXCR4-treated groups (Figure
7d). In contrast to eosinophil accumulation, the accumulation
of polymorphonuclear cell population in the epidermis was
not affected (Figure 7d). These results suggest a role for
CXCR4/CXCL12 interaction in the migration of eosinophils to
the skin in the process of epithelialization following burn
inflection.
DISCUSSION
Burn wound healing is a complex process consisting of an
early phase of energy depletion and necrosis, followed by a
two-stage inflammatory phase, formation of granulation
tissue, matrix formation, and remodeling (Clark, 1988; Cotran
et al., 1999; Spies et al., 2002). The numerous cellular and
humoral interactions during these phases of thermal wound
healing are complex and not well understood. Partial skin
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Figure 5. Coexpression of vimentin and CXCL12 in rat burned skin.
(a) Immunohistochemical staining for vimentin of rat burned skin dermis 5 days
after burn. (b) CXCL12 immunohistochemical staining of consecutive tissue
section of rat burned skin section 5 days after burn (Original magnification
400; arrow indicates the staining for CXCL12 and vimentin). Coexpression
of GPF and CXCL12 in heterozygous mice bearing a GFP reporter knocked-in
to the CX3CR1 locus burned skin. (c and d) Accumulation of GFPþ
monocyte/dendritic cells in the dermis of injured skin. (e–h) Coexpression of
GFPþ CXCL12 in monocyte/dendritic cells in parallel sections from dermis
of injured skin; arrow indicates the staining for CXCL12 and GFP.
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burn wounds could be more effectively treated sooner if the
blister wall was maintained intact (Ono et al., 1995). Burn
wound fluids from blisters contain relatively large amounts of
cytokines such as platelet-derived growth factor, IL-6,
transforming growth factor-b, and IL-8 thought to stimulate
the wound healing process by regulating epithelialization
(Ono et al., 1995; Struzyna et al., 1995). The increased
CXCL12 levels in human burn fluid during the first 3 days
following burn injury (Figure 3b) and the expression of
CXCR4 by human keratinocytes (Figure 4a) may support the
survival and tissue organization of these cells. This concept is
supported by studies showing that CXCR4 is expressed by
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Figure 6. CXCL12 is expressed in primary cultures of fibroblasts, but not in keratinocytes. (a) In vitro expression of CXCL12 and CXCR4 in keratinocytes and
fibroblasts. Expression of CXCL12 and CXCR4 measured by RT-PCR in primary human keratinocytes and fibroblasts. Expression of CXCL12 in keratinocytes- and
fibroblasts-conditioned medium as measured by ELISA assay. (b) Immunostaining of human primary fibroblasts with anti-cytokeratin antibodies as control.
(c) Immunostaining of human primary fibroblasts with anti CXCL12 antibodies. (d) Immunostaining of human primary fibroblasts with anti-CXCL12 of human
primary fibroblast 2 days after wounding the fibroblasts monolayer. (Original magnifications 40 and 200). Fib.=fibroblasts; Ker.=keratin.
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Figure 7. Effect of neutralizing antibodies to CXCR4 and the small peptide inhibitor of CXCR4 on inflammation and regeneration of skin following burns.
(a) Migration of rat lymphocytes in response to CXCL12 (100 ng/ml) was tested in the absence and presence of neutralizing antibodies to CXCR4 (NA), or the
CXCR4 antagonist – 4F-benzoyl-TN14003. (b) The effect of CXCR4 antagonists on re-epithelialization. (c) Depicts the epithelialization of burned skin in mice
treated with phosphate-buffered saline (PBS) (asterisk indicates the sites of novel epithelialization). (d) Depicts the epithelialization of burned skin in mice treated
with 4F-benzoyl-TN14003 (asterisk indicates the sites of novel epithelialization). The number of lymphocytes in the dermis is shown in (e). The number of
polymorponuclear cells (PMN) in the epidermis and eosinophils in the dermis 5 days after burn is shown in (f). (g) Depicts the eosinophils in the dermis of mice
treated with PBS (arrow indicates the site of eosinophilia). (h) Depicts the eosinophils in the dermis of mice treated with 4F-benzoyl-TN14003 (arrow indicates
the site of eosinophilia). The results are the average of two experiments; for each experiment at least five rats were tested (Po0.05).
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skin keratinocytes and is essential for keratinocytes that
participate in maintaining skin integrity (Smith et al., 2004).
The restricted presence of functional CXCL12 (24–48 hours
following burn) may suggest a protective role for CXCL12 in
the maintenance of skin tissue following burn. In contrast to
the presence of CXCL12 in human burn fluid during the first 3
days following injury, an increased number of fibroblasts and
dendritic cells that expressed CXCL12 are observed in the
regenerating skin in the first 2 weeks following damage. This
difference may be the result of increased levels of proteolytic
activity in the burn fluid. Indeed, a variety of proteolytic
enzymes such as cathepsin G, elastase, and matric metallo-
proteinase-9 were recently shown to degrade CXCL12 (Petit
et al., 2002).
In partial-thickness burns, the epidermis and the super-
ficial dermis are destroyed and undergo necrosis (Clark,
1988; Cotran et al., 1999; Singer and Clark, 1999). Twenty-
four hours to 2 days following burns, the affected area lost
CXCL12 expression. However, the expression of CXCL12 in
the area adjacent to the burn wound was intensed. During
this time period, a massive influx of neutrophils into the
wound area was observed. The accumulation of neutrophils
could not be blocked by CXCR4 antagonists, suggesting that
CXCR4/CXCL12 axes have no detectable role in this process.
The accumulation of neutrophils in the wound area was
associated with an increased production of the neutrophil
chemoattractants neutrophil activating protein-2 (NAP-2),
Growth-Regulated Oncogene alpha (GRO-a), and Epithelial
neutrophil activating peptide-78 (ENA-78), as well as with the
sustained production of IL-8 in human burn blisters in human
(Figure 3a) (Faunce et al., 1999; Piccolo et al., 1999; Gillitzer
and Goebeler, 2001). In partial-thickness burns, the prolifer-
ating and migrating epithelium arose from the wound border
as well as from hair follicles. The rate of epithelial cover was
modulated by growth factors that stimulated the proliferation
and chemotaxsis of epithelial cells (Clark, 1988; Cotran et al.,
1999; Singer and Clark, 1999). During the granulation
phase, beginning 2–3 days following damage, fibroblasts
attracted by macrophages migrated into the wound area;
these fibroblasts from swine and rat origin secreted high
levels of CXCL12 (Figures 4 and 5). The process of
granulation is associated with intense angiogenesis (Cotran
et al., 1999; Singer and Clark, 1999). In parallel to migration
of fibroblasts expressing high levels of CXCL12, novel and
resident endothelial cells lining the blood vessels also
expressed CXCL12. During this phase of wound healing, a
second wave of immune cells entered the epidermis under-
lying the burn. These cells include macrophages, lympho-
cytes, and eosinophils. The chemokines CCL2, CXCL10,
CXCL9, and CCL22 were found to be spatially associated
with lymphocyte and monocyte accumulation (Gibran et al.,
1997; Gillitzer and Goebeler, 2001). We found a minor effect
of CXCR4 antagonists on the recruitment of macrophages and
lymphocytes, whereas the recruitment of eosinophils was
totally blocked (Figure 7).
A fine balance between fibrotic tissue deposition and
neovascularization on the one hand and fibrotic tissue
degradation and epithelization on the other should be
maintained in order to assure successful wound healing.
Immune cell subpopulation recruited to the burned site is
involved in orchestrating these events. Unbalanced prolifera-
tion and activation of fibroblasts may lead to inadequate
granulation and the formation of a fibrotic tissue. However,
reduced angiogenesis and blood flow into the burn wound
can prevent successful epithelialization and wound repair.
With regard to the CXCL12/CXCR4 axis, we have found
that the most dramatic effect of CXCR4 antagonists was on
the number of infiltrating eosinophils. The decrease in
eosinophil migration into the wounded tissue and the
increased epithelialization observed in mice treated
with CXCR4 antagonist indicate that CXCL12/CXCR4
interactions are involved in shaping the balance between
fibrosis and epithelialization. Moreover, these data may
suggest that eosinophils are linked to the regulation of
epithelialization.
Indeed, it was reported by Yang et al. (1997) that anti-
interleukin-5 mAB (TRFK-5) treatment can deplete eosino-
phils in healing of cutaneous wounds and that wound closure
by re-epithelialization in the treated animals was 4 days faster
than in the control group. This study suggests a role for
eosinophils in negatively affecting wound re-epithelializa-
tion. Neutralizing antibodies to CXCR4 and AMD3100, an
antagonist of CXCR4/CXCL12 interaction, were shown to
reduce lung eosinophilia, indicating that CXCR4-mediated
signals contribute to lung inflammation in a mouse model of
allergic airway disease (Gonzalo et al., 2000; Lukacs et al.,
2002). Eosinophils constitutively express CC chemokine
receptor 3 and, to a lesser extent, CC chemokine receptor
1. CC chemokine receptor 3 is mainly responsible for
migration of resting eosinophils, and its specific ligand,
eotaxin, represents the most potent chemoattractant for
eosinophils (Nagase et al., 2001b). However, eosinophils in
inflamed tissue sites exhibited a decreased CC chemokine
receptor 3 and an increased CXCR4 expression (Nagase et al.,
2001a). Surface CXCR4 protein was hardly detectable in the
peripheral blood or freshly isolated eosinophils. Similarly to
the phenomenon observed with eosinophils in inflamed
tissues, surface expression of CXCR4 became gradually
apparent during in vitro incubation of cells. CXCL12, the
natural ligand of CXCR4, elicited an apparent Ca2þ influx in
these cells and induced a strong migratory response compar-
able to that by eotaxin (Nagase et al., 2000)
In summary, we suggest that the presence of CXCL12 in
burn blisters is involved in protecting the skin during a short
period of time following skin burn injury. Thereafter, CXCL12
expressed by fibroblasts and endothelial cells may induce the
accumulation of eosinophils, which in turn slow the
epithelialization. Our data suggest that CXCL12 is more
predominantly supporting fibrosis than epithelialization.
Indeed, we and others have recently shown that during liver
fibrosis, the levels of CXCL12 expression by endothelial cells
and fibroblasts are dramatically increased (Wald et al., 2004).
It is therefore possible that by using inhibitors against CXCR4,
the balance between fibrosis and epithelialization can be
changed, thereby leading to a better and faster recovery of
skin following damage.
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MATERIALS AND METHODS
Human cell lines
Human skin fibroblasts and keratinocytes were obtained from skin
biopsies. Fibroblasts were grown in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal calf serum, and keratinocytes
were cultured in H. Green keratinocyte-specific medium (Green
et al., 1979). Keratinocytes and fibroblasts were kindly provided by
Professor Ben-Basst Laboratory, Hadassah University Hospital,
Jerusalem, Israel. Cells were passaged weekly by trypsinization.
Bone marrow endothelial cells are microvascular endothelial cells
isolated from human bone marrow aspirates. The bone marrow
endothelial cell-1 cell line was kindly provided by S Rafii. This cell
line was generated by introducing the SV40-large T antigen into an
early passage of primary bone marrow endothelial cell, and it has
retained the morphology, phenotype, and function of the primary
bone marrow endothelial cell. The bone marrow endothelial cell-1
cells were cultured in a complete DMEM and were passaged weekly
by trypsinization.
Immunohistochemistry and in vitro scratched assay
Skin tissue samples were routinely fixed with formalin and
embedded in paraffin. Antigen retrieval was performed in ethylene-
diaminetetraacetic acid buffer for 15 minutes in microwave, and
sections were stained with mAB (MAB 350) (R&D Systems Inc.,
Minneapolis, MN) for CXCL12 (1:100) mAB0 against cytokeratins 1,
5, 15, and 10 (M0630) (DAKO, Glostrup, Denmark) and mAB anti-
vimentin (M7020) (DAKO), mAB against rat CXCR4 (Torrey Pines
Biolabs, Houston, TX), using biotinylated secondary polymer
(87–9,963) (Zymed) based on standard indirect avidin–biotin horse-
radish peroxidase method, according to the manufacturer’s instruc-
tions. 3-amino-9-ethylcarbazole was used for color development
and sections were counterstained with hematoxylin. Cell immuno-
histochemistry staining: keratinocyte and fibroblast monolayers were
grown in a tissue culture 6 mm plates. Then, cells were scratched
using a 200ml pipette, washed three times with phosphate - buffered
saline (PBS), and grown in DMEM with 1% fetal calf serum. After 2
days, cells were fixed using 4% paraformaldehyde and stained for
the chemokine CXCL12 as described previously.
ELISA assay and RT-PCR
ELISA assays for CXCL12 and IL-8 in burn fluids of fibroblast and
keratinocyte medium were performed using the Quantikine kit (R&D
Systems Inc., Minneapolis, Minnesota), according to the manufac-
turer’s instructions. The expression levels of the chemokine CXCL12
and the chemokine receptor CXCR4 were determined by RT-PCR
analysis. Total RNA was isolated from primary fibroblast and
keratinocyte cultures. Each RNA sample was subjected to cDNA
synthesis, and then semiquantative PCR was performed with specific
primers at appropriate annealing temperatures. The resulting PCR
products were separated on 1% agarose gel.
Transwell migration assays
Rat peripheral blood cells were loaded on Ficoll (Histopaque-1077-1,
Sigma), and the peripheral blood mononuclear cells were isolated.
Rat peripheral blood mononuclear cell migration was assessed in 24-
well chemotaxis chambers (6.5-mm diameter, 5-mm pore poly-
carbonate transwell culture insert; Costar, Cambridge, Massachu-
setts). RPMI 1640 (600 ml) with 1% BSA (migration buffer) with or
without 100 ng/ml of CXCL12a (Peprotech, Rehovot, Israel) were
added to the lower wells, and 2 105 cells suspended in 100 ml
of RPMI 1640 with 1% BSA were added to the upper wells.
After 3 hours incubation, the membrane was removed and migrating
cells were counted for 1 minute using fluorescence activated cell
sorter.
Tissue collection, histological evaluation of the burn lesion
Human skin tissue samples were obtained from the Plastic Surgery
Department, Souraski Medical Center, Tel-Aviv. In order to examine
the different phases in burn wound healing and the involvement of
the chemokine CXCL12 and the receptor CXCR4, the following
experiments were carried out. Wistar female rats were anesthetized
and their back was shaved. Burns (1 cm2) were inflicted with a metal
rod that has been immersed in a hot boiling water bath and laid on
the posterior part of the hip and back for 2–3 seconds. All
experiments were approved by the Animal care committee of the
Medical Center, Tel-Aviv and the Hebrew University. All
the material collected from human specimens was approved by
Tel-Aviv Sourasky Medical Center Institutional Committee and in
adherence to the Declaration of Helsinki Principles. Heterozygous
mice bearing a GFP reporter knocked-in allele to the CX3CR1 locus
(Qu et al., 2004) were maintained at the Weizmann Institute of
Science Animal Facility. Each group of three rats was injected
subcutaneously with either PBS, anti-CXCR4, or with 4F-benzoyl-
TN14003 to the burned area. Animals were killed at the indicated
times after burn infliction: 0, 6 hours, 1 day, 3 days, 5 days, and 7
days. Histopathological diagnosis was confirmed for each specimen.
Histological sections were prepared from formalin-fixed, paraffin-
embedded tissues stained with hematoxylin and eosin. The evalua-
tion to the level of epithelialization and white blood cells in the
epidermis and dermis was made to each section by a scale from 1 to
5. The sections were scored by two independent pathologists.
Treated rats were injected subcutaneously to the burned area with
one of the following: PBS, mAB against rat CXCR4, the small peptide
CXCR4 inhibitor, or 4F-benzoyl-TN14003. All animals were killed
120 hours after injury. Histopathological diagnosis was confirmed
for each specimen. Histological sections were prepared from
formalin-fixed, paraffin-embedded tissues stained with hematoxylin
and eosin. The evaluation to the level of epithelialization and white
blood cells in the dermis was made to each section by a scale from 1
to 5. The grading scale was as follows: 0¼ no inflammation or
epithelialization; 1¼ low inflammation or epithelialization; 2¼ low
to moderate inflammation or epithelialization; 3¼moderate inflam-
mation or epithelialization; 4¼ high inflammation or epithelializa-
tion; and 5¼ very high inflammation or epithelialization.
Swine burned skin paraffin-embedded sections were provided by
the Laboratory of Experimental Surgery, Hadassah University
Hospital, Jerusalem, Israel. All experiments were approved by the
Animal Care Committee of the Hebrew University. Burn blister fluid
collection was collected at the Plastic Surgery Department, Souraski
Medical Center, Tel-Aviv, Israel as a medical procedure. The blister
fluid was examined for the chemokine CXCL12 levels by ELISA
assay, and for the levels of IL-8.
Statistical analysis
Results are expressed as mean7SD. Statistical differences were
determined by an analysis of two-tailed Student’s t-test.
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